97. 潰瘍性大腸炎 Ulcerative colitis Clinical trials / Disease details
臨床試験数 : 2,630 / 薬物数 : 1,459 - (DrugBank : 265) / 標的遺伝子数 : 144 - 標的パスウェイ数 : 202
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT05588843 (ClinicalTrials.gov) | November 25, 2022 | 17/10/2022 | Dose-finding Study of SAR443122 in Adult Participants With Ulcerative Colitis | A Randomized, Double-blind, Placebo Controlled, Dose-finding Study to Assess the Efficacy and Safety of SAR443122 in Adult Patients With Moderate to Severe Ulcerative Colitis | Colitis Ulcerative | Drug: SAR443122;Drug: Placebo | Sanofi | NULL | Recruiting | 18 Years | 75 Years | All | 182 | Phase 2 | United States;Argentina;Chile;United Kingdom |